Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.

Publication

Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.

Journal Paper/Review - Nov 9, 2023

Boormans Joost L, Sylvester Richard, Anson-Cartwright Lynn, Glicksman Rachel M, Hamilton Robert J, Hahn Ezra, Daugaard Gedske, Lauritsen Jakob, Wagner Thomas, Avuzzi Barbara, Nicolai Nicola, del Muro Xavier Garcia, Aparicio Jorge, Stalder Odile, Rothermundt Christian, Fischer Stefanie, Laguna Maria P

Citation

Boormans J, Sylvester R, Anson-Cartwright L, Glicksman R, Hamilton R, Hahn E, Daugaard G, Lauritsen J, Wagner T, Avuzzi B, Nicolai N, del Muro X, Aparicio J, Stalder O, Rothermundt C, Fischer S, Laguna M. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office. Eur Urol Oncol 2023

Type

Journal Paper/Review (English)

Journal

Eur Urol Oncol 2023

Publication Date

Nov 9, 2023

Issn Electronic

2588-9311

Brief description/objective

The relapse rate in patients with clinical stage I (CSI) seminomatous germ cell tumor of the testis (SGCTT) who were undergoing surveillance after radical orchidectomy is 4-30%, depending on tumor size and rete testis invasion (RTI). However, the level of evidence supporting the use of both risk factors in clinical decision-making is low.